Synageva BioPharma (GEVA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts GEVA Hot Sheet
Join SI Premium – FREE
Synageva BioPharma (NASDAQ: GEVA) reported Q1 EPS of ($1.73), $0.02 worse than the analyst estimate of ($1.71).
For earnings history and earnings-related data on Synageva BioPharma (GEVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
